To compare the outcomes of neonates who received surfactant for breathing difficulty with neonates who did not, in an advanced neonatal care unit in South India.
Not Applicable
- Conditions
- Health Condition 1: P073- Preterm [premature] newborn [other]
- Registration Number
- CTRI/2022/05/042379
- Lead Sponsor
- Riya Asokan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All inborn neonates with respiratory distress born between 23-34 weeks.
Exclusion Criteria
Newborns >34 weeks gestation at birth
All out born babies
Infants who received surfactant for indications other than RDS (Eg; Pulmonary hemorrhage, Meconium aspiration)
Infants with fatal congenital anomalies
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the mortality rate of preterm infants who received surfactant with infants who did not receive surfactant. <br/ ><br>Timepoint: The outcomes will be assessed at the time of discharge / death. (However, all the date are collected retrospectively)
- Secondary Outcome Measures
Name Time Method To evaluate the following outcomes : <br/ ><br>The major morbidities (ROP, BPD, IVH) <br/ ><br>To evaluate the incidence of Type I RDS in preterm neonates less than 34 weeks. <br/ ><br>The length of NICU stay <br/ ><br>Duration of invasive / non-invasive ventilation <br/ ><br>Impact of early versus late surfactant administration (less than 6 hrs and after 6hrs) <br/ ><br>Timepoint: 3 months